Share-based Payment Arrangement, Expense of Boundless Bio, Inc. from 31 Mar 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Boundless Bio, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2023 to 30 Sep 2025.
  • Boundless Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,303,000, a 36% decline year-over-year.
  • Boundless Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $6,801,000, a 6% increase year-over-year.
  • Boundless Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $7,516,000, a 125% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Boundless Bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,801,000 $1,303,000 -$742,000 -36% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $7,543,000 $1,693,000 -$442,000 -21% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $7,985,000 $1,797,000 +$469,000 +35% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $7,516,000 $2,008,000 +$1,097,000 +120% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $6,419,000 $2,045,000 +$1,162,000 +132% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $5,257,000 $2,135,000 +$1,208,000 +130% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $4,049,000 $1,328,000 +$713,000 +116% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $3,336,000 $911,000 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $883,000 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $927,000 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $615,000 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1

Boundless Bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $7,516,000 +$4,180,000 +125% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $3,336,000 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.